TheScreener - Ramco Cements (MADRASCEM) THE RAMCO CEMENTS sees a downgrade to Neutral on account of less fundamental stars

Report

TheScreener

EUR 13.66 For Business Accounts Only

THE RAMCO CEMENTS sees a downgrade to Neutral on account of less fundamental stars

The independent financial analyst theScreener just lowered the general evaluation of THE RAMCO CEMENTS (IN), active in the Building Materials & Fixtures industry. As regards its fundamental valuation, the title now shows 0 out of 4 stars while market behaviour can be considered defensive. theScreener believes that the title remains under pressure due to the loss of a star(s) and downgrades its general evaluation to Neutral. As of the analysis date May 4, 2021, the closing price was INR 961.60 and its target price was estimated at INR 835.57.

05/05/2021 1 EN

Underlying

Ramco Cements

Ramco Cements is engaged in the manufacture and production of cement, ready mix concrete and dry mortar products in India. Co. operates in three divisions: Cement; Drymix Products and Ramco Concete. In the Cement Division, Co.'s main product is Portland Cement, which is manufactured in eight production facilities that include integrated cement plants and grinding units. Co.'s Dry Mix Division manufactures pre mixed dry mortars such as plasters, wall putty and tile adhesive. Co.'s Ramco Concrete Division manufactures concrete based on customers requirements such as permutations based on concrete grades, workability and site conditions. Co. also operates a wind farm in India.

See profile

INE331A01037 National Stock Exchange of India India

Provider

TheScreener

Empowering Investors

theScreener is the market leader for independent valuations of financial securities, equities, sectors and markets, and new funds. theScreener's ratings, analyses are used by leading banks, asset managers and financial portals. Approximately 10,000 workstations benefit from theScreener's services, with over millions of customer accounts actively analysed.

Worldwide coverage: theScreener analyses cover around 6'500 Stocks, i.e 95% of the world Market Capitalization. theScreener state of art: We provide
theScreener state of art: We provide easy to use and complete analyses over Stocks, including Fundamentals / Technical / Risk/ Peer / Alternatives analyses.
For Research Pool community, we provide twice a week around 500 new equity analyses. We produce analyses about equities which have been upgraded or downgraded.

See profile

Other Reports on these Companies

Motilal Oswal

MOSL: THE RAMCO CEMENTS: Cost under control; volume growth surprises

. THE RAMCO CEMENTS: Cost under control; volume growth surprises (TRCL IN, Mkt Cap USD2.2b, CMP INR752, TP INR785, 4% Upside, Downgrade to Neutral) Aims at 15% volume growth in FY23; downgrade to Neutral from Buy Strong volume growth (up 55% YoY and 13% above our estimate), along with controlled costs (variable cost up a mere INR75/t QoQ), aided the significant beat from our estimate. EBITDA and OPM stood at INR3b and 17% (est. INR2.4b and 15%), respectively. Profit stood at INR1.1b (est. INR0.7b). The management expects volume growth of 15% in FY23 and a decline in energy costs from 3Q...

EUR 120.00

August 2, 2022 August 2, 2022 8 EN

SmartInsider

Ramco Cements Ltd: 1 director

A director at Ramco Cements Ltd sold 76,500 shares at 739.872INR and the significance rating of the trade was 67/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showing Close periods where trading activity is restricted under listing rules. The names of b...

Free Trial

March 17, 2022 March 17, 2022 1 EN

Motilal Oswal

MOSL: THE RAMCO CEMENTS (Upgrade to Buy)-Optimistic on demand, but wary of near-term cost inflation

THE RAMCO CEMENTS: Optimistic on demand, but wary of near-term cost inflation (TRCL IN, Mkt Cap USD3b, CMP INR944, TP INR1106, 17% Upside, Upgrade to Buy) Upgrade to Buy on strong volume growth opportunities TRCL's 2QFY22 result reflects volume recovery in South India, post the slowdown seen during COVID-19 lockdowns. Volume improved by 27% QoQ and 23% YoY, which helped it to operate its clinker plants at 74% capacity. The company remains a play on the volume recovery theme and one of the better picks in the Cement space, led by its capacity expansion plans (clinker capacity increase ...

EUR 120.00

October 26, 2021 October 26, 2021 12 EN

AC ENERGY CORP increases its risk exposure and slightly lowers to Neutral

AC ENERGY CORP (PH), a company active in the Alternative Electricity industry, now shows a lower overall rating. The independent financial analyst theScreener confirms the fundamental rating of 4 out of 4 stars. However, the market behaviour deterioration triggered a risk requalification, which can be thus described as moderately risky. theScreener believes that increased risk justifies the general evaluation downgrade to Neutral. As of the analysis date April 8, 2022, the closing price was PHP 8.54 and its expected value was estimated at PHP 8.53.

Free Trial

April 9, 2022 April 9, 2022 1 EN

With a more favourable environment, VUKILE PROPERTY improves to Positive

VUKILE PROPERTY (ZA), a company active in the Real Estate Holding & Development industry, is favoured by a more supportive environment. The independent financial analyst theScreener has confirmed the fundamental rating of the title, which shows 4 out of 4 stars, as well as its unchanged, defensive market behaviour. The title leverages a more favourable environment and raises its general evaluation to Positive. As of the analysis date April 5, 2022, the closing price was ZAR 13.72 and its potential was estimated at ZAR 15.16.

Free Trial

April 6, 2022 April 6, 2022 1 EN

An unfavourable environment weighs on ROYAL BAFOKENG PLATINUM, which sees a downgrade to Slightly Negative

The independent financial analyst theScreener just requalified the general evaluation of ROYAL BAFOKENG PLATINUM (ZA), active in the Platinum & Precious Metals industry. As regards its fundamental valuation, the title still shows 0 out of 4 stars and its market behaviour is seen as moderately risky. theScreener believes that the unfavourable environment weighs on the sector and penalises the company, which sees a downgrade to its general evaluation to Slightly Negative. As of the analysis date April 5, 2022, the closing price was ZAR 159.78 and its target price was estimated at ZAR 127.50.

Free Trial

April 6, 2022 April 6, 2022 1 EN

Sign-up for free to access full reports immediately

Email Address*

Choose Password* ( 6 or more characters )

Due to regulatory restrictions regarding the distribution of financial research, this report is restricted to a specific region or investor type. Get access to exclusive reports by answering the questions below.

Select your country*

Get financial insights straight to your inbox

By clicking "register" you accept the Terms and Conditions & Privacy Policy

Already on ResearchPool?

Almost there...

Are you a professional investor?

Select your country

REGISTER

Create a free ResearchPool account to access full reports, get a personalised dashboard and follow providers or companies

In order to access this report please create an account.

LOGIN

THE RAMCO CEMENTS sees a downgrade to Neutral on account of less fundamental stars

Empowering Investors

MOSL: THE RAMCO CEMENTS: Cost under control; volume growth surprises

Ramco Cements Ltd: 1 director

MOSL: THE RAMCO CEMENTS (Upgrade to Buy)-Optimistic on demand, but wary of near-term cost inflation

AC ENERGY CORP increases its risk exposure and slightly lowers to Neutral

With a more favourable environment, VUKILE PROPERTY improves to Positive

An unfavourable environment weighs on ROYAL BAFOKENG PLATINUM, which sees a downgrade to Slightly Negative

Create a free ResearchPool account to access full reports, get a personalised dashboard and follow providers or companies

Sign-up for free to access full reports immediately

ResearchPool Subscriptions

Get the most out of your insights

Why subscribe?

How to subscribe

ResearchPool Subscriptions

This report is only available to subscribers

Why subscribe?

How to subscribe